Note*: This report requires 7-10 business days to complete.
DelveInsight’s Idiopathic Thrombocytopenic Purpura (ITP) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Idiopathic Thrombocytopenic Purpura (ITP) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Idiopathic Thrombocytopenic Purpura (ITP) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Idiopathic Thrombocytopenic Purpura (ITP) market.
• Identifying patient populations in the global “Idiopathic Thrombocytopenic Purpura (ITP)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Idiopathic Thrombocytopenic Purpura (ITP) therapeutics in each of the markets covered.
• To understand the future market competition in the global Idiopathic Thrombocytopenic Purpura (ITP) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Idiopathic Thrombocytopenic Purpura (ITP) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Idiopathic Thrombocytopenic Purpura (ITP) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Idiopathic Thrombocytopenic Purpura (ITP) Market
• Global Epidemiology of Idiopathic Thrombocytopenic Purpura (ITP) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Idiopathic Thrombocytopenic Purpura (ITP) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Idiopathic Thrombocytopenic Purpura (ITP) (2013-2023)
• Table 7: Idiopathic Thrombocytopenic Purpura (ITP) Global Market (USD Millions), (2013-2015)
• Table 8: Idiopathic Thrombocytopenic Purpura (ITP) Global Market (USD Millions), (2016-2023)
• Table 9: Idiopathic Thrombocytopenic Purpura (ITP) US Market (USD Millions), (2013-2015)
• Table 10: Idiopathic Thrombocytopenic Purpura (ITP) US Market (USD Millions), (2016-2023)
• Table 11: Idiopathic Thrombocytopenic Purpura (ITP) Germany Market (USD Millions), (2013-2015)
• Table 12: Idiopathic Thrombocytopenic Purpura (ITP) Germany Market (USD Millions), (2016-2023)
• Table 13: Idiopathic Thrombocytopenic Purpura (ITP) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Idiopathic Thrombocytopenic Purpura (ITP) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Idiopathic Thrombocytopenic Purpura (ITP) France Market (USD Millions), (2013-2015)
• Table 16: Idiopathic Thrombocytopenic Purpura (ITP) France Market (USD Millions), (2016-2023)
• Table 17: Idiopathic Thrombocytopenic Purpura (ITP) Italy Market (USD Millions), (2013-2015)
• Table 18: Idiopathic Thrombocytopenic Purpura (ITP) Italy Market (USD Millions), (2016-2023)
• Table 19: Idiopathic Thrombocytopenic Purpura (ITP) Spain Market (USD Millions), (2013-2015)
• Table 20: Idiopathic Thrombocytopenic Purpura (ITP) Spain Market (USD Millions), (2016-2023)
• Table 21: Idiopathic Thrombocytopenic Purpura (ITP) Japan Market (USD Millions), (2013-2015)
• Table 22: Idiopathic Thrombocytopenic Purpura (ITP) Japan Market (USD Millions), (2016-2023)
• Table 23: Idiopathic Thrombocytopenic Purpura (ITP) ROW Market (USD Millions), (2013-2015)
• Table 24: Idiopathic Thrombocytopenic Purpura (ITP) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Idiopathic Thrombocytopenic Purpura (ITP) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Idiopathic Thrombocytopenic Purpura (ITP) (2013-2023)
• Figure 3: Idiopathic Thrombocytopenic Purpura (ITP) Global Market (USD Millions), (2013-2015)
• Figure 4: Idiopathic Thrombocytopenic Purpura (ITP) Global Market (USD Millions), (2016-2023)
• Figure 5: Idiopathic Thrombocytopenic Purpura (ITP) US Market (USD Millions), (2013-2015)
• Figure 6: Idiopathic Thrombocytopenic Purpura (ITP) US Market (USD Millions), (2016-2023)
• Figure 7: Idiopathic Thrombocytopenic Purpura (ITP) Germany Market (USD Millions), (2013-2015)
• Figure 8: Idiopathic Thrombocytopenic Purpura (ITP) Germany Market (USD Millions), (2016-2023)
• Figure 9: Idiopathic Thrombocytopenic Purpura (ITP) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Idiopathic Thrombocytopenic Purpura (ITP) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Idiopathic Thrombocytopenic Purpura (ITP) France Market (USD Millions), (2013-2015)
• Figure 12: Idiopathic Thrombocytopenic Purpura (ITP) France Market (USD Millions), (2016-2023)
• Figure 13: Idiopathic Thrombocytopenic Purpura (ITP) Italy Market (USD Millions), (2013-2015)
• Figure 14: Idiopathic Thrombocytopenic Purpura (ITP) Italy Market (USD Millions), (2016-2023)
• Figure 15: Idiopathic Thrombocytopenic Purpura (ITP) Spain Market (USD Millions), (2013-2015)
• Figure 16: Idiopathic Thrombocytopenic Purpura (ITP) Spain Market (USD Millions), (2016-2023)
• Figure 17: Idiopathic Thrombocytopenic Purpura (ITP) Japan Market (USD Millions), (2013-2015)
• Figure 18: Idiopathic Thrombocytopenic Purpura (ITP) Japan Market (USD Millions), (2015-2023)
• Figure 19: Idiopathic Thrombocytopenic Purpura (ITP) ROW Market (USD Millions), (2013-2015)
• Figure 20: Idiopathic Thrombocytopenic Purpura (ITP) ROW Market (USD Millions), (2016-2023)
• 3SBio Inc.
• Amgen Inc.
• Baxalta Incorporated
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Eisai Co. Ltd.
• Hansa Medical AB
• Immunomedics Inc.
• Intas Pharmaceuticals Ltd.
• Jiangsu Hengrui Medicine Co. Ltd.
• Merck & Co. Inc.
• Momenta Pharmaceuticals Inc.
• Novartis AG
• Pfizer Inc.
• PhytoHealth Corporation
• Protalex Inc.
• Rigel Pharmaceuticals Inc.
